Prentiss Smith & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Sell |
|
|||||
|
2025
Q1 | $5.34M | Sell |
|
|||||
|
2024
Q4 | $4.7M | Sell |
|
|||||
|
2024
Q3 | $5.56M | Sell |
|
|||||
|
2024
Q2 | $5.2M | Sell |
|
|||||
|
2024
Q1 | $4.77M | Sell |
|
|||||
|
2023
Q4 | $5.1M | Sell |
|
|||||
|
2023
Q3 | $5.3M | Sell |
|
|||||
|
2023
Q2 | $5.3M | Sell |
|
|||||
|
2023
Q1 | $4.84M | Sell |
|
|||||
|
2022
Q4 | $4.83M | Sell |
|
|||||
|
2022
Q3 | $4.1M | Sell |
|
|||||
|
2022
Q2 | $4.58M | Sell |
|
|||||
|
2022
Q1 | $4.83M | Sell |
|
|||||
|
2021
Q4 | $4.96M | Sell |
|
|||||
|
2021
Q3 | $4.64M | Sell |
|
|||||
|
2021
Q2 | $5.19M | Sell |
|
|||||
|
2021
Q1 | $4.96M | Sell |
|
|||||
|
2020
Q4 | $6.13M | Sell |
|
|||||
|
2020
Q3 | $5.74M | Sell |
|
|||||
|
2020
Q2 | $5.94M | Buy |
|
|||||
|
2020
Q1 | $5.61M | Sell |
|
|||||
|
2019
Q4 | $6.49M | Sell |
|
|||||
|
2019
Q3 | $6.05M | Sell |
|
|||||
|
2019
Q2 | $6.38M | Sell |
|
|||||
|
2019
Q1 | $8.86M | Sell |
|
|||||
|
2018
Q4 | $10.4M | Sell |
|
|||||
|
2018
Q3 | $10.5M | Sell |
|
|||||
|
2018
Q2 | $9.31M | Sell |
|
|||||
|
2018
Q1 | $10.3M | Buy |
|
|||||
|
2017
Q4 | $10.6M | Buy |
|
|||||
|
2017
Q3 | $10.8M | Sell |
|
|||||
|
2017
Q2 | $10.8M | Sell |
|
|||||
|
2017
Q1 | $10.1M | Buy |
|
|||||
|
2016
Q4 | $9.7M | Sell |
|
|||||
|
2016
Q3 | $10.7M | Sell |
|
|||||
|
2016
Q2 | $11.2M | Buy |
|
|||||
|
2016
Q1 | $9.69M | Buy |
|
|||||
|
2015
Q4 | $11.2M | Buy |
|
|||||
|
2015
Q3 | $11.7M | Buy |
|
|||||
|
2015
Q2 | $12M | Sell |
|
|||||
|
2015
Q1 | $12.9M | Sell |
|
|||||
|
2014
Q4 | $12.7M | Sell |
|
|||||
|
2014
Q3 | $13.1M | Sell |
|
|||||
|
2014
Q2 | $12.8M | Sell |
|
|||||
|
2014
Q1 | $12.2M | Sell |
|
|||||
|
2013
Q4 | $11.8M | Sell |
|
|||||
|
2013
Q3 | $12M | Buy |
|
|||||
|
2013
Q2 | $5.65M | Buy |
|